These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 28483551)
1. Antiviral activity of formyl peptide receptor 2 antagonists against influenza viruses. Courtin N; Fotso AF; Fautrad P; Mas F; Alessi MC; Riteau B Antiviral Res; 2017 Jul; 143():252-261. PubMed ID: 28483551 [TBL] [Abstract][Full Text] [Related]
2. The Annexin A1 Receptor FPR2 Regulates the Endosomal Export of Influenza Virus. Rahman F; Chebbo M; Courtin N; Fotso Fotso A; Alessi MC; Riteau B Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29738458 [TBL] [Abstract][Full Text] [Related]
3. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase. Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558 [TBL] [Abstract][Full Text] [Related]
4. Germacrone inhibits early stages of influenza virus infection. Liao Q; Qian Z; Liu R; An L; Chen X Antiviral Res; 2013 Dec; 100(3):578-88. PubMed ID: 24095670 [TBL] [Abstract][Full Text] [Related]
5. Antiviral activity of novel oseltamivir derivatives against some influenza virus strains. Kocik J; Kołodziej M; Joniec J; Kwiatek M; Bartoszcze M Acta Biochim Pol; 2014; 61(3):509-13. PubMed ID: 25210935 [TBL] [Abstract][Full Text] [Related]
6. Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses. Park JG; Ávila-Pérez G; Nogales A; Blanco-Lobo P; de la Torre JC; Martínez-Sobrido L J Virol; 2020 Mar; 94(7):. PubMed ID: 31941776 [TBL] [Abstract][Full Text] [Related]
7. [Study of the antiviral activity of Russian anti-influenza agents in cell culture and animal models]. Leneva IA; Fediakina IT; Eropkin MIu; Gudova NV; Romanovskaia AA; Danilenko DM; Vinogradova SM; Lepeshkin AIu; Shestopalov AM Vopr Virusol; 2010; 55(3):19-27. PubMed ID: 20608077 [TBL] [Abstract][Full Text] [Related]
8. Cryptoporic acid E from Cryptoporus volvatus inhibits influenza virus replication in vitro. Gao L; Han J; Si J; Wang J; Wang H; Sun Y; Bi Y; Liu J; Cao L Antiviral Res; 2017 Jul; 143():106-112. PubMed ID: 28232246 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments. Matusevich OV; Egorov VV; Gluzdikov IA; Titov MI; Zarubaev VV; Shtro AA; Slita AV; Dukov MI; Shurygina AP; Smirnova TD; Kudryavtsev IV; Vasin AV; Kiselev OI Antiviral Res; 2015 Jan; 113():4-10. PubMed ID: 25446335 [TBL] [Abstract][Full Text] [Related]
10. Inhibition effects of novel polyketide compound PPQ-B against influenza A virus replication by interfering with the cellular EGFR pathway. Wang M; Wang S; Wang W; Wang Y; Wang H; Zhu W Antiviral Res; 2017 Jul; 143():74-84. PubMed ID: 28414053 [TBL] [Abstract][Full Text] [Related]
12. Discovery of dihydro-alkyloxy-benzyl-oxopyrimidines as promising anti-influenza virus agents. Yu M; Liu A; Du G; Naesens L; Vanderlinden E; De Clercq E; Liu X Chem Biol Drug Des; 2011 Oct; 78(4):596-602. PubMed ID: 21752202 [TBL] [Abstract][Full Text] [Related]
13. Chemical Genomics Approach Leads to the Identification of Hesperadin, an Aurora B Kinase Inhibitor, as a Broad-Spectrum Influenza Antiviral. Hu Y; Zhang J; Musharrafieh R; Hau R; Ma C; Wang J Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885544 [TBL] [Abstract][Full Text] [Related]
14. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against influenza virus isolates in the 2011-2012 season in Japan. Ikematsu H; Kawai N; Iwaki N; Kashiwagi S J Infect Chemother; 2014 Feb; 20(2):77-80. PubMed ID: 24560563 [TBL] [Abstract][Full Text] [Related]
15. In vitro anti-influenza A activity of interferon (IFN)-λ1 combined with IFN-β or oseltamivir carboxylate. Ilyushina NA; Donnelly RP Antiviral Res; 2014 Nov; 111():112-20. PubMed ID: 25245230 [TBL] [Abstract][Full Text] [Related]
17. Susceptibility of influenza viruses to hypothiocyanite and hypoiodite produced by lactoperoxidase in a cell-free system. Patel U; Gingerich A; Widman L; Sarr D; Tripp RA; Rada B PLoS One; 2018; 13(7):e0199167. PubMed ID: 30044776 [TBL] [Abstract][Full Text] [Related]
18. Antiviral drug susceptibilities of seasonal human influenza viruses in Lebanon, 2008-09 season. Zaraket H; Saito R; Wakim R; Tabet C; Medlej F; Reda M; Baranovich T; Suzuki Y; Dapat C; Caperig-Dapat I; Dbaibo GS; Suzuki H J Med Virol; 2010 Jul; 82(7):1224-8. PubMed ID: 20513088 [TBL] [Abstract][Full Text] [Related]
19. Mycophenolic acid, an immunomodulator, has potent and broad-spectrum in vitro antiviral activity against pandemic, seasonal and avian influenza viruses affecting humans. To KKW; Mok KY; Chan ASF; Cheung NN; Wang P; Lui YM; Chan JFW; Chen H; Chan KH; Kao RYT; Yuen KY J Gen Virol; 2016 Aug; 97(8):1807-1817. PubMed ID: 27259985 [TBL] [Abstract][Full Text] [Related]
20. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012-2013 season. Ikematsu H; Kawai N; Iwaki N; Kashiwagi S J Infect Chemother; 2015 Jan; 21(1):39-42. PubMed ID: 25277670 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]